VD

Vamil Divan

#110 out of 1699 analysts
Guggenheim
Automatically Tracked
Tracking: 0 Updated: Jun 18 at 07:35 PM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
73.29%
Gain +4.93%
Monthly
0.69%
Yearly
8.56%
Drawdown
20.42%
$1.05M
Equity
Holdings
$1.05M
Cash
$1,714.33
Investment
$1.01M
$533,970.22
Profit +$49,326.36
Realized
$497,375.86
Unrealized
$36,594.36
Dividends
$0
$1,714.33
Cash
Deposits
$516,737.81
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
4.93%
Profit
$49,326.36
Win %
100%
This Week
Compared To Last Week
Gain
2.37%
Profit
$24,295.34
Win %
66%
This Month
Compared to last month
Gain
-0.2%
Profit
-$2,055.71
Win %
66%
This Year
Compared to last year
Gain
8%
Profit
$77,785.28
Win %
60%
Absci Corporation logo
ABSI Absci Corporation
+2.3%
+$16,300.78
Unicycive Therapeutics Inc. logo
UNCY Unicycive Therapeutics Inc.
-3.83%
+$10,552.78
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
323
Longs Won
172/313 54%
Profit Factor
1.84
Profitability
Shorts Won
2/10 20%
Standard Deviation
$10,906.14
Average Win
$6,722.11
Best Trade
(Jun 06) $78,164.2
Sharpe Ratio
-181.79
Average Loss
-$4,266.29
Worst Trade
(Jun 15) -$55,505.56
Z-Score
-3.7 (100%)
Commissions
$0
Avg. Trade Length
1m 4w
Expectancy
$1,653.16
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% 0.15% 4.69%
Consecutive Losing Trades 246 222 197 172 148 123 99 74 49 25
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV